BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18812013)

  • 1. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
    Kindlundh-Högberg AM; Zhang X; Svenningsson P
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):201-15. PubMed ID: 18812013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
    Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
    Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
    Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
    Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.
    Cox BM; Shah MM; Cichon T; Tancer ME; Galloway MP; Thomas DM; Perrine SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():229-35. PubMed ID: 24121061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
    Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
    J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
    Ludwig V; Mihov Y; Schwarting RK
    Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
    Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
    Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
    Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
    Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
    Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
    Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
    Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
    Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.
    Huff C; Bhide N; Schroering A; Yamamoto BK; Gudelsky GA
    Brain Res Bull; 2013 Feb; 91():52-7. PubMed ID: 23318273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.
    Trigo JM; Renoir T; Lanfumey L; Hamon M; Lesch KP; Robledo P; Maldonado R
    Biol Psychiatry; 2007 Sep; 62(6):669-79. PubMed ID: 17306775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.